文献速递心脏核医学肿瘤 PET/CT

心脏PET/CT联合相位分析检测心脏结节病瘢痕:与CMR对比

Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging.
PubMed 文献 · J Nucl Cardiol · 2021-01-20

研究纳入176例疑似心脏结节病患者,在3个月内完成CMR和N-13氨/18F-FDG心脏PET/CT检查,以CMR延迟钆增强(LGE)且无对应18F-FDG摄取定义为瘢痕。PET/CT检测瘢痕的灵敏度为45.3%、特异度88.9%,加入PET衍生的左室容积与功能及相位分析数据后灵敏度提升至57.0%,AUC提高至0.75。

要点

  • 门控PET心肌灌注显像单独检测心脏结节病瘢痕灵敏度仅45.3%。
  • 加入PET衍生容积与功能数据后灵敏度升至57.0%(特异度80.0%,AUC 0.72)。
  • 相位分析最大节段收缩起始时间>61使AUC升至0.75,净重分类指数8.2%。

核心结论

  • 门控PET心肌灌注显像单独检测心脏结节病瘢痕灵敏度欠佳。
  • 加入PET衍生容积/功能与相位分析数据可改善瘢痕检测与表征。

研究设计与样本

  • 纳入176例疑似心脏结节病患者,均在3个月内完成CMR与N-13氨/18F-FDG心脏PET/CT。
  • 瘢痕定义为CMR延迟钆增强(LGE)且无对应18F-FDG摄取。
  • 评估PET/CT检测瘢痕(灌注缺损且无对应18F-FDG摄取)的准确性,并比较加入自动PET衍生数据前后的表现。

主要发现

  • PET/CT检测瘢痕的灵敏度为45.3%,特异度为88.9%。
  • 逻辑回归模型加入PET衍生左室容积与功能后,灵敏度提升至57.0%,特异度80.0%,AUC 0.72。
  • 加入相位分析最大节段收缩起始时间>61后,AUC提升至0.75,16.3%患者被正确重新标记为瘢痕,净重分类指数8.2%。

关键数值与推荐

  • 瘢痕判定标准:CMR LGE阳性且无对应18F-FDG摄取。
  • PET/CT瘢痕判定标准:灌注缺损且无对应18F-FDG摄取。
  • 相位分析阈值:最大节段收缩起始时间>61。

临床怎么用

  • 对疑似心脏结节病患者,可考虑在门控PET心肌灌注显像基础上加入PET衍生左室容积、功能及相位分析数据以提高瘢痕检出。
  • PET/CT检测瘢痕灵敏度有限,阴性结果不能完全排除瘢痕,需结合CMR综合判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The presence of myocardial scar in CS patients results in poor prognosis and worse outcomes. 18F-fluorodeoxyglucose (18F-FDG) PET/CT excels at visualizing inflammation but is suboptimal at detecting scar. We evaluated PET/CT sensitivity to detect scar and investigated the incremental diagnostic value of automated PET-derived data. METHODS: 176 patients who underwent cardiac magnetic resonance (CMR) and N-13 ammonia/18F-FDG cardiac PET/CT for suspected CS within 3 months were enrolled. Scar was defined as late gadolinium enhancement (LGE) on CMR without concordant 18F-FDG uptake on 18F-FDG PET/CT. Accuracy of cardiac PET/CT at detecting scar (perfusion defect without concordant 18F-FDG uptake) was assessed before and after addition of automated PET-derived data. RESULTS: Sensitivity of PET/CT for scar detection was 45.3% (specificity 88.9%). Addition of PET-derived LV volumes and function in a logistic regression model improved sensitivity to 57.0% (specificity: 80.0%, AUC 0.72). Addition of phase analysis maximum segmental onset of myocardial contraction > 61 improved AUC to 0.75, correctly relabeling 16.3% of patients as scar (net reclassification index 8.2%). CONCLUSION: Sensitivity of gated PET MPI alone for scar detection in CS is suboptimal. Adding PET-derived volumes/function and phase analysis data results in improved detection and characterization of scar.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Elwazir MY, Bird JG, AbouEzzeddine OF, et al. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging. J Nucl Cardiol. 2021. PMID: 33474694. doi:10.1007/s12350-020-02473-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。